Antiglycan antibodies in greek patients with inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 56, Issue 3, 2011, Pages 845-852

  Koutroubakis, Ioannis E ^a   Drygiannakis, Dimitrios ^b   Tsirogianni, Alexandra ^c   Oustamanolakis, Pantelis ^a   Karmiris, Konstantinos ^a   Papamichael, Konstantinos ^c   Mantzaris, Gerassimos J ^c   Kouroumalis, Elias A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b General Hospital of Rethymnon   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Anti Saccharomyces cerevisiae antibodies; Crohn's disease; Serological markers; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CHITOBIOSIDE CARBOHYDRATE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMINARIOBIOSIDE CARBOHYDRATE ANTIBODY; MANNOBIOSIDE CARBOHYDRATE ANTIBODY; SACCHAROMYCES CEREVISIAE MANNAN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL INDICATOR; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; ENZYME IMMUNOASSAY; FEMALE; GREECE; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; GREECE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79952440160     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1328-9     Document Type: Article

References (22)

1. JF Quinton B Sendid D Reumaux, et al. 1998 Anti- Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 42 788 791 1:CAS:528:DyaK1cXlslChs7o%3D 10.1136/gut.42.6.788 9691915 (Pubitemid 28277217)
2. M Peeters S Joossens S Vermeire R Vlietinck X Bossuyt P Rutgeerts 2001 Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 730 734 1:STN:280:DC%2BD3M7ovFOktg%3D%3D 10.1111/j.1572-0241.2001.03613.x 11280542 (Pubitemid 32240723)
3. WJ Sandborn EV Loftus Jr.JF Colombel, et al. 2001 Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease Inflamm Bowel Dis 7 192 201 1:STN:280: DC%2BD3MvntFSiuw%3D%3D 10.1097/00054725-200108000-00003 11515844 (Pubitemid 32776511)
4. IE Koutroubakis E Petinaki IA Mouzas, et al. 2001 Anti Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease Am J Gastroenterol 96 449 454 1:CAS:528:DC%2BD3MXisVGhtL0%3D 11232689
5. A Zholudev D Zurakowski W Young A Leichtner A Bousvaros 2004 Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype Am J Gastroenterol 99 2235 2241 10.1111/j.1572-0241.2004.40369.x 15555007 (Pubitemid 39524716)
6. WS Mow EA Vasiliauskas YC Lin, et al. 2004 Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease Gastroenterology 126 414 424 1:CAS:528:DC%2BD2cXhvV2rsbg%3D 10.1053/j.gastro.2003.11.015 14762777 (Pubitemid 38182298)
7. SR Targan CJ Landers H Yang, et al. 2005 Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease Gastroenterology 128 2020 2028 1:CAS:528:DC%2BD2MXlvFKltrs%3D 10.1053/j.gastro.2005.03.046 15940634 (Pubitemid 40824710)
8. MC Dubinsky YC Lin D Dutridge, et al. 2006 Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression Am J Gastroenterol 101 360 367 10.1111/j.1572-0241. 2006.00456.x 16454844 (Pubitemid 43381681)
9. I Dotan S Fishman Y Dgani, et al. 2006 Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease Gastroenterology 131 366 378 1:CAS:528:DC%2BD28XpsFyksr0%3D 10.1053/j.gastro. 2006.04.030 16890590 (Pubitemid 44142445)
10. X Li L Conklin P Alex 2008 New serological biomarkers of inflammatory bowel disease World J Gastroenterol 14 5115 5124 1:CAS:528: DC%2BD1MXmtVCmtA%3D%3D 10.3748/wjg.14.5115 18777587
11. M Ferrante L Henckaerts M Joossens, et al. 2007 New serological markers in inflammatory bowel disease are associated with complicated disease behaviour Gut 56 1394 1403 10.1136/gut.2006.108043 17456509 (Pubitemid 47517833)
12. M Papp I Altorjay N Dotan, et al. 2008 New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort Am J Gastroenterol 103 665 681 1:CAS:528:DC%2BD1cXkslKmtb0%3D 10.1111/j.1572-0241.2007.01652.x 18047543 (Pubitemid 351405992)
13. D Simondi G Mengozzi S Betteto, et al. 2008 Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease Inflamm Bowel Dis 14 645 651 10.1002/ibd.20368 18240283 (Pubitemid 351742981)
14. F Rieder S Schleder A Wolf, et al. 2010 Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior Inflamm Bowel Dis 16 263 274 10.1002/ibd.21255 19653286
15. EF Stange SPL Travis S Vermeire, et al. 2006 European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis Gut 55 1 15 10.1136/gut.2005. 081950a (Pubitemid 43268290)
16. MS Silverberg J Satsangi T Ahmad, et al. 2005 Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 Suppl A 5 36 16151544
17. WR Best JM Becktel JW Singleton F Kern Jr.1976 Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study Gastroenterology 70 439 444 1:STN:280:DyaE287hvVGmtg%3D%3D 1248701
18. RS Walmsley RC Ayres RE Pounder RN Allan 1998 A simple clinical colitis activity index Gut 43 29 32 1:STN:280:DyaK1cvksVensw%3D%3D 10.1136/gut.43.1.29 9771402 (Pubitemid 28335486)
19. N Dotan RT Altstock M Schwarz A Dukler 2006 Anti-glycan antibodies as biomarkers for diagnosis and prognosis Lupus 15 442 450 1:CAS:528: DC%2BD28Xos1ykurw%3D 10.1191/0961203306lu2331oa 16898180 (Pubitemid 44147091)
20. Rieder F, Schleder S, Wolf A, et al. Serum anti-glycan antibodies predict complicated Crohn's disease behavior: A cohort study. Inflamm Bowel Dis. 2010 [Epub ahead of print] PMID: 20024902.
21. M Joossens K Van Steen J Branche, et al. 2010 Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease Inflamm Bowel Dis 16 58 67 19504613
22. S Joossens W Reinisch S Vermeire, et al. 2002 The value of serologic markers in indeterminate colitis: a prospective follow-up study Gastroenterology 122 1242 1247 10.1053/gast.2002.32980 11984510 (Pubitemid 34465166)